Gelteq is trading at $0.58, up 7.81%, with no confirmed company-specific announcement explaining its October 6, 2026 gain.
- Major U.S. indexes were also higher, supporting a broadly positive market backdrop, but this does not establish a direct cause for the move.
- Biotech-sector context was negative: XBI was down 2.50%. Recent company news appears older, and no trading-volume data was provided.